Evaluation of a Device for Negative Selection of CD34+ Cells Alone or in Combination with Breast Cancer Tumor Cell Purging

Publisher： Karger

E-ISSN： 1660-3818|28|2|67-72

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.28, Iss.2, 2001-04, pp. : 67-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD34-Negative Stem Cells

By  

Transfusion Medicine and Hemotherapy, Vol. 26, Iss. 2, 2004-11 ,pp. : 2-5

Karger

Access to resources Recommend Favorite

Preclinical Evaluation of ZD1839 Alone or in Combination with Oxaliplatin in a Panel of Human Tumor Cell Lines – Implications for Clinical Use

By  

Oncology Research and Treatment, Vol. 28, Iss. 10, 2005-09 ,pp. : 482-488

Karger

Access to resources Recommend Favorite

Adenovirus p53 Purging for Human Breast Cancer Stem Cell Products

By  

Acta Haematologica, Vol. 101, Iss. 2, 1999-04 ,pp. : 97-105

Karger

Access to resources Recommend Favorite

Immunomagnetic Tumor Cell Enrichment Is Promising in Detecting Circulating Breast Cancer Cells

By  

Oncology, Vol. 64, Iss. 2, 2003-02 ,pp. : 160-165

Karger

Access to resources Recommend Favorite

Selection of CD34-Positive Blood Cells for Allogeneic Transplantation: Approaches to Optimize D34-Cell Recovery, Purity, Viability, and T-cell Depletion

By  

Oncology Research and Treatment, Vol. 23, Iss. 5, 2000-11 ,pp. : 449-456

Karger

Access to resources Recommend Favorite